In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

As early as 2005, Gritz and colleagues drew attention to clinical trialists missing the potential impact of tobacco use on cancer treatment outcomes, as smoking status was rarely recorded in cancer ...

A groundbreaking new medical dataset is poised to revolutionize health care in Africa by improving chatbots' understanding of ...

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...

Broadly speaking, opportunity risk can be thought of as “the potential loss or missed opportunity that an organization faces ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

President Donald Trump’s plan to boost artificial intelligence and build data centers across the U.S. could speed up a building boom that was already expected to strain the nation’s ability ...

Each year, the World Economic Forum (WEF) releases its Technology Pioneers list – a curated collection of companies that are ...

The first step in reducing the risk of artificial intelligence-associated psychosis is to correct misunderstandings about ...

Three companies led by Indian origin entrepreneurs — Qure.ai led by Prashant Warier, CRISPR Therapeutics led by Sam Kulkarni and Vertex Pharmaceuticals led by Reshma Kewalramani — figure among TIME100 ...

What was once considered science fiction — remote diagnostics, AI in surgery, 3D-printed organs — has become medical reality. The next 30 years will redefine what it means to be treated, cured and car ...

President Donald Trump’s 23-page AI Action Plan, released on Wednesday, won’t transform the AI industry overnight, but it ...